CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 31 filers reported holding CHAMPIONS ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $875 | -100.0% | 194,010 | -44.1% | 0.99% | -69.8% |
| Q3 2022 | $2,602,000 | -8.1% | 346,976 | -2.0% | 3.28% | +23.9% |
| Q2 2022 | $2,832,000 | +5.9% | 354,041 | +7.6% | 2.65% | +36.4% |
| Q1 2022 | $2,675,000 | -1.9% | 328,980 | +0.9% | 1.94% | +22.2% |
| Q4 2021 | $2,726,000 | -17.6% | 326,136 | +0.6% | 1.59% | -23.1% |
| Q3 2021 | $3,309,000 | +14.8% | 324,075 | +15.6% | 2.07% | +37.5% |
| Q2 2021 | $2,883,000 | -1.9% | 280,439 | +7.8% | 1.50% | -5.0% |
| Q1 2021 | $2,939,000 | +49.4% | 260,082 | +42.6% | 1.58% | +15.6% |
| Q4 2020 | $1,967,000 | +77.0% | 182,337 | +51.8% | 1.37% | +52.4% |
| Q3 2020 | $1,111,000 | +113.7% | 120,109 | +121.0% | 0.90% | +69.1% |
| Q2 2020 | $520,000 | -14.8% | 54,357 | -34.1% | 0.53% | -42.3% |
| Q1 2020 | $610,000 | -26.4% | 82,495 | -17.1% | 0.92% | +2.1% |
| Q4 2019 | $829,000 | – | 99,547 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Battery Partners IX, LLC | 1,953,549 | $7,111,000 | 7.42% |
| NEA Management Company, LLC | 1,562,500 | $5,688,000 | 0.25% |
| SHEPHERD KAPLAN KROCHUK, LLC | 21,564 | $78,000 | 0.05% |
| Perceptive Advisors | 366,973 | $1,335,000 | 0.04% |
| Granite Investment Partners, LLC | 139,698 | $509,000 | 0.03% |
| Sandy Spring Bank | 8,333 | $30,000 | 0.00% |
| Veritas Investment Management (UK) Ltd | 2,083 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,753 | $6,000 | 0.00% |
| VANGUARD GROUP INC | 152,722 | $553,000 | 0.00% |
| MORGAN STANLEY | 3,500 | $13,000 | 0.00% |